Protocol summary

Study aim
Determination of the effect of hydrocortisone on hemodynamic changes including arterial blood pressure and heart rate resulting from the neuromuscular relaxant atracurium
Design
A clinical trial with the control group, with parallel groups, double-blind, randomized, phase 3 on 48 patients. G * Power software was used for randomization.
Settings and conduct
The present study will be a double-blind randomized clinical trial (patient and outcome assessor) performed on individuals aged 15 to 60 years to determine the effects of hydrocortisone on hemodynamic changes induced by atracurium for intubation in patients under general anesthesia referred to 5 Azarshahr Medical Center. Gorgan will be done in 2022.
Participants/Inclusion and exclusion criteria
Inclusion criteria: All patients for elective upper limb fracture surgery between the ages of 15-60 with ASA I or II, Exclusion criteria: neuromuscular disorders, receiving antibiotics including aminoglycosides 24 hours before surgery, liver disease And kidney, diabetes, heart failure, allergy to corticosteroids, obesity, taking H1 histamine blocker one day before surgery, lactating and pregnant mothers, psychotic disorders,hypothyroidism,Osteoporosis
Intervention groups
Intervention group: 100 mg Jaber hydrocortisone vial with the generic name: Hydrocortisone-Systemic (manufacturer of Jaber Bin Hayan Pharmacy [Iran]) once, 30 minutes before entering the operating room (in the ward) intravenously and bolus with 300 ml They receive normal saline under the supervision of a nurse who has no knowledge of the study groups. Control group: Individuals in the placebo group received the same amount of distilled water with 300 ml of normal saline under the supervision of a nurse who is unaware of the drug groups.
Main outcome variables
Hemodynamic changes Bronchospasm Number of breaths

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20170108031818N2
Registration date: 2022-04-20, 1401/01/31
Registration timing: prospective

Last update: 2022-04-20, 1401/01/31
Update count: 0
Registration date
2022-04-20, 1401/01/31
Registrant information
Name
fatemeh mehravar
Name of organization / entity
Golestan University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 912 893 7199
Email address
mehravar10261@goums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2022-04-30, 1401/02/10
Expected recruitment end date
2022-07-01, 1401/04/10
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of the effectiveness of hydrocortisone and placebo (distilled water) on hemodynamic changes in atracurium for intubation in patients with upper limb fractures (candidate for elective surgery)
Public title
Evaluation of the effects of hydrocortisone on hemodynamic changes in patients under general anesthesia
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
All patients for elective surgery between the ages of 15-60 with ASA I or II
Exclusion criteria:
All patients for elective surgery between the ages of 15-60 with ASA I or II Metabolic and neuromuscular disorders People if they receive strong antibiotics effective on the effects of relaxants, including aminoglycosides 24 hours before surgery Significant liver and kidney disease Known allergies to narcotics and other drugs used during anesthesia if he took the H1 histamine blocker the day before surgery Obesity (if ideal body weight> 30)
Age
From 15 years old to 60 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Outcome assessor
Sample size
Target sample size: 48
Randomization (investigator's opinion)
Randomized
Randomization description
Participants in the study were assigned to the intervention (B) and control (A) groups by block randomization. Using a dice that has 6 sides, the samples are assigned to their groups. A number is written on each side and each number is assigned to one of the blocks in the table, which has its own special mode. it shows. Group A (hydrocortisone) and B (placebo of distilled water). A complete list of randomized blocks was provided to the lead researcher by the study epidemiologist.
Blinding (investigator's opinion)
Double blinded
Blinding description
Blinding in this study is double-blind. After obtaining the consent of the participants, they are blind to their study groups and the preparation and dilution of the drug, which are similar in appearance (size, shape, volume of the manufacturer) is done by the nurse in charge of the department. Minutes before entering the operating room (in the ward), people in the hydrocortisone group receive 100 mg of hydrocortisone intravenously and bolus with 300 ml of normal saline. The doctor in charge of the plan and the intervener will not know the type of drug group. Anesthesia induction will be performed by the project resident resident who has no role in the study outcome process.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics Committee of Golestan University of Medical Sciences
Street address
Gorgan, 4 km, Sari, Golestan University of Medical Sciences, Gorgan, Iran. Deputy of Research and Technology of Gorgan, Gorgan, Gorgan
City
Gorgan
Province
Golestan
Postal code
4934174515
Approval date
2021-11-28, 1400/09/07
Ethics committee reference number
IR.GOUMS.REC.1400.318

Health conditions studied

1

Description of health condition studied
Patients for elective surgery for upper limb fractures
ICD-10 code
T10
ICD-10 code description
Fracture of upper limb, level unspecified

Primary outcomes

1

Description
hemodynamic changes
Timepoint
Hemodynamics will be recorded in the relevant list before the administration of hydrocortisone and 30 minutes after the administration of hydrocortisone or at the entrance to the operating room and 5 minutes after the peak effect of atracurium (before intubation) and after ecstasy.
Method of measurement
This monitoring will be performed under the supervision of an anesthesiologist based on patient monitoring instructions, including continuous monitoring of heart rate, arterial oxygen saturation and intermittent and non-invasive measurement of systolic and diastolic blood pressure and bronchospasm by Saadat's monitoring device.

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group: Individuals in the hydrocortisone group receive 100 mg of hydrocortisone intravenously and bolus with 300 ml of normal saline under the supervision of a nurse who is unaware of the drug groups.
Category
Treatment - Drugs

2

Description
Control group: Individuals in the placebo group receive the same amount of distilled water with 300 ml of normal saline under the supervision of a nurse who is unaware of the drug groups.
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Gorgan 5 Azar Educational and Medical Center
Full name of responsible person
Kazem Kazemnejad Tabrizi
Street address
Gorgan, 4 km, Sari, Golestan University of Medical Sciences, Gorgan, Iran. Deputy of Research and Technology of Gorgan, Gorgan, Gorgan
City
gorgan
Province
Golestan
Postal code
4934174515
Phone
+98 17 3223 8363
Email
mehravar10261@yahoo.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Gorgan University of Medical Sciences
Full name of responsible person
Mohammad Reza Honarvar
Street address
Gorgan, 4 km, Sari, Golestan University of Medical Sciences, Gorgan, Iran. Deputy of Research and Technology of Gorgan, Gorgan, Gorgan
City
gorgan
Province
Golestan
Postal code
4934174515
Phone
+98 17 3223 8363
Email
honarvar@goums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Gorgan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Gorgan University of Medical Sciences
Full name of responsible person
Kazem Kazemnejad Tabrizi
Position
Associate Professor
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Gorgan, 4 km, Sari, Golestan University of Medical Sciences, Gorgan, Iran. Deputy of Research and Technology of Gorgan, Gorgan, Gorgan
City
Gorgan
Province
Golestan
Postal code
4934174515
Phone
+98 17 3223 8363
Email
mehravar10261@yahoo.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Gorgan University of Medical Sciences
Full name of responsible person
Kazem Kazemnejad Tabrizi
Position
Associate Professor
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Gorgan, 4 km, Sari, Golestan University of Medical Sciences, Gorgan, Iran. Deputy of Research and Technology of Gorgan, Gorgan, Gorgan
City
Gorgan
Province
Golestan
Postal code
4934174515
Phone
+98 17 3223 8363
Fax
Email
mehravar10261@yahoo.com

Person responsible for updating data

Contact
Name of organization / entity
Gorgan University of Medical Sciences
Full name of responsible person
Kazem Kazemnejad Tabrizi
Position
Associate Professor
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Gorgan, 4 km, Sari, Golestan University of Medical Sciences, Gorgan, Iran. Deputy of Research and Technology of Gorgan, Gorgan, Gorgan
City
Gorgan
Province
Golestan
Postal code
4934174515
Phone
+98 17 3223 8363
Email
mehravar10261@yahoo.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...